Document is current
Any future updates will be listed below
-
Authors
Khan, Qamar J. https://orcid.org/0000-0002-6287-020X
Bivona, Cory R.
Liu, Ben
Nelson, Maggie
Martin, Grace A.
Mushtaq, Muhammad Umair
Sharma, Priyanka
Streeter, Natalie R.
Hoffmann, Marc
Doolittle, Gary C.
Zhong, Cuncong
Mitchell, Laura
Li, Kevin H.
Pessetto, Ziyan Y.
Ghosh, Arnab
Pathak, Harsh B.
Zhang, Jun https://orcid.org/0000-0001-7886-6187
Godwin, Andrew K. https://orcid.org/0000-0002-3987-9580
McGuirk, Joseph P. https://orcid.org/0000-0002-0539-4796
- License Information
-
More Information
Article History
Received: 23 December 2021
Revised: 11 March 2022
Accepted: 18 March 2022
First Online: 6 April 2022
Competing interests
: AKG and ZYP are co-founders of Sinochips Diagnostics; PS serves as advisory board member and consultant to Merck, Novartis, Exact Sciences, Seattle Genetics, Immunomedics, Myriad Genetics, AstraZeneca, Puma Biotechnology; JZ served as a scientific advisor/consultant for AstraZeneca, Biodesix, Novocure, Bayer, Daiichi Sankyo, Mirati, Novartis, Cardinal Health, Bristol Myers Squibb, Nexus Health and Sanofi and is on the speakers’ bureau for AstraZeneca and MJH Life Sciences and has received research funding from AstraZeneca, Biodesix, Novartis, Genentech/Roche, Mirati, AbbVie and Hengrui Therapeutics; GCD serves on an advisory board for Novartis; JPM serves as advisory board member and consultant to Novartis, Kite Pharmaceuticals, BMS and Allovir; MH received consulting fees from Janssen, Pharmacyclics, Novartis Inc., Kite Pharmaceuticals and TG therapeutics. The remaining authors declare no competing interests.
Free to read: This content has been made available to all.
